<qa>  What is the outcome of immunochemotherapy?The investigators will evaluate response rate, progression free survival PFS, overall survival OS, and toxicity in elderly patients with primary central nervous system lymphoma PCNSL after systemic and intrathecal immunochemotherapy with deferred radiotherapy. 